Welcome to The Catalyst
Change isn't quick. Unless it's when you experience Intravascular Lithotripsy (IVL) for the first time. Stay apprised of our latest news and insights while discovering how a simple and intuitive tool can be The Catalyst to change the way you think about calcium modification.
In a few weeks, we are headed to a city known for its sunshine and southern hospitality, Atlanta, Georgia, where SCAI 2022 is taking place this year. At the conference, leading calcium experts will share the 1-year results from the Randomized Disrupt PAD III Trial and 1-year sex specific outcomes with Coronary IVL.
Topics: Coronary IVL, IVL Case, Peripheral IVL, Shockwave Breaking News, IVL Technology, DISRUPT PAD, Coronary Cases, Peripheral Cases, PAD Applications - BTK, Peripheral Conferences, SWAV News, Shockwave C2, Coronary Conferences, Shockwave M5, Shockwave S4, PAD Applications - TEVAR, Coronary IVL - U.S., ShockwaveM5+
On Thursday, November 18, join us and six IVL experts at VEITH 2021 to hear how Intravascular Lithotripsy (IVL) works across multiple vessel beds.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Cases, Peripheral Conferences, Peripheral Clinical Data
Calcium causes a magnitude of problems in EVAR and TEVAR procedures. Calcium can inhibit stent graft delivery leading to significant dissection or perforation of the iliac arteries. Calcium can also affect expansion of iliac limbs leading to increased risk of under expansion and stent graft thrombosis.
Watch as Dr. Stefano Fazzini, Tor Vergata University Hospital, Italy walks you through how Shockwave IVL can help alleviate access challenges while minimizing complications and the need for secondary interventions.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Cases, Peripheral Conferences, Peripheral Clinical Data
We’ve all heard that Shockwave IVL doesn’t work in eccentric calcium… well that’s just a myth. Watch Prof. Andrew Holden’s presentation from CIRSE21 as he walks you through IVL’s eccentric vs concentric lesion data subset from the PADIII Observational Study and learn how this myth can well and truly be dispelled.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Cases, Peripheral Conferences, Peripheral Clinical Data
Dr. Ehrin Armstrong presented the interim results from the first 752 patients in the Disrupt PAD III Observational Study (OS), reinforcing the consistency of IVL's unique mechanism of action to safely and effectively modify superficial and deep calcium across multiple vessel beds, lesion types and CLI patients.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Cases, Peripheral Conferences, Peripheral Clinical Data
If you are attending VIVA21, you may not be dealing cards, but you’re likely dealing with peripheral artery calcium. So join Dr. Sahil Parikh, Dr. Ehrin Armstrong, Dr. Venita Chandra and Dr. Peter Soukas at 12pm Pacific Time on Wednesday, October 6th in the Bandol Room to make sure you don’t gamble with your calcium strategy. Listen to the esteemed panel during the Shockwave Medical Symposium and you learn how Intravascular Lithotripsy (IVL) can help you beat the odds.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Cases, Peripheral Conferences, Peripheral Clinical Data
Learn about IVL’s unique mechanism of action in fracturing severe, superficial and deep calcium and the clinical outcomes associated with IVL in the coronary and peripheral vasculature.
Topics: DISRUPT CAD, IVL Technology, DISRUPT PAD, Coronary Clinical Data, Peripheral Clinical Data
From Data to Daily Practice; Disrupting Calcium with IVL across multiple vessel beds.
Topics: Medical Meetings, Peripheral IVL, DISRUPT PAD, Peripheral Conferences, Peripheral Clinical Data
The treatment of calcified below-the-knee (BTK) lesions is challenging, associated with sub-optimal procedural outcomes, resulting in early recoil, and may contribute to restenosis.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Cases, PAD Applications - BTK, PAD Applications - CLI, Peripheral Clinical Data
Following the excitement of the PAD III RCT results presented at VIVA in November, a rock star faculty of Prof. Gunnar Tepe, Prof. Thomas Zeller, Dr. Arne Schwindt and Dr. Lorenzo Patrone assembled for an incathlab session to discuss the study results and how IVL offers superior vessel preparation over conventional PTA in severely calcified PAD lesions.
Topics: Peripheral IVL, DISRUPT PAD, Peripheral Clinical Data
But, right now we're in the early phases of the R&D program. In the meantime, don't miss the IVL application that heart teams are embracing already — maintaining transfemoral TAVR access through heavily calcified iliacs by using IVL.
